Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HHIP-like protein 1 (HHIPL1) is a secreted protein encoded by the *HHIPL1* gene on chromosome 14q32[1][3][5]. It is homologous to the Hedgehog-interacting protein (HHIP) and contains a scavenger receptor cysteine-rich (SRCR) domain and a signal peptide for secretion[3][5]. HHIPL1 enhances Hedgehog signaling, positively regulating smooth muscle cell proliferation and migration, and is pro-atherogenic—meaning its activity promotes the development of atherosclerosis[1]. Genome-wide association studies have identified *HHIPL1* variants as risk loci for coronary artery disease[1][3]. The gene is also hypermethylated in certain adenomas, making it a potential biomarker for these tumors[3]. Unlike its paralog HHIP, no drugs are currently known to target HHIPL1, nor is there evidence that it serves as a direct therapeutic target at this time[3][5]. Further functional characterization and potential for druggability remain to be established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HHIP-like protein 1 (HHIPL1).